Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q3 2025 Earnings Call Transcript November 10, 2025
Capricor Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $-0.54 EPS, expectations were $-0.54.
Operator: Good afternoon, ladies and gentlemen. And welcome to the Capricor Therapeutics Third Quarter 2025 Conference Call. At this time, all participants are in a listen-only mode. If at any time during this call, you require immediate assistance, please press 0 for the...
